Anti-AA2AR/ ADORA2A/ A2aR monoclonal antibody

Anti-AA2AR/ ADORA2A/ A2aR antibody for FACS & in-vivo assay

Target products collectionGo to ADORA2A/ADORA2A products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T77365-Ab-1/ GM-Tg-hg-T77365-Ab-2Anti-Human ADORA2A monoclonal antibodyHuman
GM-Tg-rg-T77365-Ab-1/ GM-Tg-rg-T77365-Ab-2Anti-Rat ADORA2A monoclonal antibodyRat
GM-Tg-mg-T77365-Ab-1/ GM-Tg-mg-T77365-Ab-2Anti-Mouse ADORA2A monoclonal antibodyMouse
GM-Tg-cynog-T77365-Ab-1/ GM-Tg-cynog-T77365-Ab-2Anti-Cynomolgus/ Rhesus macaque ADORA2A monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T77365-Ab-1/ GM-Tg-felg-T77365-Ab-2Anti-Feline ADORA2A monoclonal antibodyFeline
GM-Tg-cang-T77365-Ab-1/ GM-Tg-cang-T77365-Ab-2Anti-Canine ADORA2A monoclonal antibodyCanine
GM-Tg-bovg-T77365-Ab-1/ GM-Tg-bovg-T77365-Ab-2Anti-Bovine ADORA2A monoclonal antibodyBovine
GM-Tg-equg-T77365-Ab-1/ GM-Tg-equg-T77365-Ab-2Anti-Equine ADORA2A monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T77365-Ab-1/ GM-Tg-hg-T77365-Ab-2; GM-Tg-rg-T77365-Ab-1/ GM-Tg-rg-T77365-Ab-2;
GM-Tg-mg-T77365-Ab-1/ GM-Tg-mg-T77365-Ab-2; GM-Tg-cynog-T77365-Ab-1/ GM-Tg-cynog-T77365-Ab-2;
GM-Tg-felg-T77365-Ab-1/ GM-Tg-felg-T77365-Ab-2; GM-Tg-cang-T77365-Ab-1/ GM-Tg-cang-T77365-Ab-2;
GM-Tg-bovg-T77365-Ab-1/ GM-Tg-bovg-T77365-Ab-2; GM-Tg-equg-T77365-Ab-1/ GM-Tg-equg-T77365-Ab-2
Products NameAnti-ADORA2A monoclonal antibody
Formatmab
Target NameADORA2A
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-ADORA2A benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species AA2AR/ ADORA2A/ A2aR VLP (virus-like particle) (Products Developing)
    ORF Viral VectorvGMAAV000023human ADORA2A AAV particle
    ORF Viral VectorpGMAAV000023human ADORA2A AAV plasmid
    ORF Viral VectorvGMAP000328Human ADORA2A Adenovirus particle
    ORF Viral VectorpGMAP000328Human ADORA2A Adenovirus plasmid
    ORF Viral VectorvGMAAV000313human ADORA2A AAV particle
    ORF Viral VectorpGMAAV000313human ADORA2A AAV plasmid
    ORF Viral VectorpGMLPm002849mouse Adora2a Lentivirus plasmid
    ORF Viral VectorvGMLPm002849mouse Adora2a Lentivirus particle


    Target information

    Target IDGM-T77365
    Target NameADORA2A
    Gene ID135,11540,25369,707865,403960,101080742,617828,100034039
    Gene Symbol and SynonymsA2AAR,A2aR,AA2AR,ADENO,ADORA2,ADORA2A,Adora2l1,ARA2A,RDC8
    Uniprot AccessionP29274,P30543,P11617,Q6TLI7
    Uniprot Entry NameAA2AR_HUMAN,AA2AR_RAT,AA2AR_CANLF,AA2AR_HORSE
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target, Immuno-oncology Target
    DiseaseN/A
    Gene EnsemblENSG00000128271
    Target ClassificationCheckpoint-Immuno Oncology

    The target: ADORA2A, gene name: ADORA2A, also named as A2aR, ADORA2, RDC8. This gene encodes a member of the guanine nucleotide-binding protein (G protein)-coupled receptor (GPCR) superfamily, which is subdivided into classes and subtypes. The receptors are seven-pass transmembrane proteins that respond to extracellular cues and activate intracellular signal transduction pathways. This protein, an adenosine receptor of A2A subtype, uses adenosine as the preferred endogenous agonist and preferentially interacts with the G(s) and G(olf) family of G proteins to increase intracellular cAMP levels. It plays an important role in many biological functions, such as cardiac rhythm and circulation, cerebral and renal blood flow, immune function, pain regulation, and sleep. It has been implicated in pathophysiological conditions such as inflammatory diseases and neurodegenerative disorders. Alternative splicing results in multiple transcript variants. A read-through transcript composed of the upstream SPECC1L (sperm antigen with calponin homology and coiled-coil domains 1-like) and ADORA2A (adenosine A2a receptor) gene sequence has been identified, but it is thought to be non-coding. [provided by RefSeq, Jun 2013].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.